Do analysts recommend CCCC or ETHZ?

C4 Therapeutics currently has a consensus price target of $7.75, indicating a potential upside of 105.30%. Given C4 Therapeutics' stronger consensus rating and higher possible upside, research analysts plainly believe C4 Therapeutics is more favorable than Flag Ship Acquisition. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score C4 Therapeutics 1 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.57 Flag Ship Acquisition 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate AUTL or ETHZ?

Autolus Therapeutics currently has a consensus target price of $8.75, indicating a potential upside of 485.28%. Given Autolus Therapeutics' stronger consensus rating and higher possible upside, research analysts plainly believe Autolus Therapeutics is more favorable than Flag Ship Acquisition. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Autolus Therapeutics 1 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 2 Strong Buy rating(s) 2.89 Flag Ship Acquisition 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate EPRX or ETHZ?

Eupraxia Pharmaceuticals currently has a consensus target price of $18.33, suggesting a potential upside of 204.79%. Given Eupraxia Pharmaceuticals' stronger consensus rating and higher probable upside, analysts plainly believe Eupraxia Pharmaceuticals is more favorable than Flag Ship Acquisition. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Eupraxia Pharmaceuticals 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 2 Strong Buy rating(s) 2.88 Flag Ship Acquisition 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is EPRX or ETHZ more profitable?

Eupraxia Pharmaceuticals' return on equity of -87.56% beat Flag Ship Acquisition's return on equity. Company Net Margins Return on Equity Return on Assets Eupraxia Pharmaceuticals N/A -87.56% -51.20% Flag Ship Acquisition N/A -185.71% -83.12%

Do analysts recommend SNDL or ETHZ?

SNDL currently has a consensus price target of $5.00, suggesting a potential upside of 253.36%. Given SNDL's stronger consensus rating and higher possible upside, research analysts plainly believe SNDL is more favorable than Flag Ship Acquisition. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SNDL 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Flag Ship Acquisition 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate ETHZ or RZLT?

Rezolute has a consensus price target of $9.38, indicating a potential upside of 102.70%. Given Rezolute's stronger consensus rating and higher possible upside, analysts clearly believe Rezolute is more favorable than Flag Ship Acquisition. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Flag Ship Acquisition 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Rezolute 1 Sell rating(s) 2 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.64

Is ETHZ or RZLT more profitable?

Rezolute's return on equity of -58.82% beat Flag Ship Acquisition's return on equity. Company Net Margins Return on Equity Return on Assets Flag Ship Acquisition N/A -185.71% -83.12% Rezolute N/A -58.82% -54.48%

Flag Ship Acquisition (ETHZ) Competitors

$5.14 -0.21 (-3.93%)

As of 06/15/2026

Compare

ETHZ vs. CCCC, AUTL, EPRX, SNDL, and RZLT

Should you buy Flag Ship Acquisition stock or one of its competitors? MarketBeat compares Flag Ship Acquisition with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Flag Ship Acquisition include C4 Therapeutics (CCCC), Autolus Therapeutics (AUTL), Eupraxia Pharmaceuticals (EPRX), SNDL (SNDL), and Rezolute (RZLT). These companies are all part of the "pharmaceutical products" industry.

How does Flag Ship Acquisition compare to C4 Therapeutics?

C4 Therapeutics (NASDAQ:CCCC) and Flag Ship Acquisition (NASDAQ:ETHZ) are both small-cap pharmaceutical products companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, profitability, risk, analyst recommendations, dividends and media sentiment.

Flag Ship Acquisition has a net margin of 0.00% compared to C4 Therapeutics' net margin of -297.76%. C4 Therapeutics' return on equity of -50.68% beat Flag Ship Acquisition's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
C4 Therapeutics	-297.76%	-50.68%	-33.22%
Flag Ship Acquisition	N/A	-185.71%	-83.12%

C4 Therapeutics has a beta of 2.91, suggesting that its share price is 191% more volatile than the broader market. Comparatively, Flag Ship Acquisition has a beta of 1.17, suggesting that its share price is 17% more volatile than the broader market.

C4 Therapeutics currently has a consensus price target of $7.75, indicating a potential upside of 105.30%. Given C4 Therapeutics' stronger consensus rating and higher possible upside, research analysts plainly believe C4 Therapeutics is more favorable than Flag Ship Acquisition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
C4 Therapeutics	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
Flag Ship Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, C4 Therapeutics had 4 more articles in the media than Flag Ship Acquisition. MarketBeat recorded 4 mentions for C4 Therapeutics and 0 mentions for Flag Ship Acquisition. C4 Therapeutics' average media sentiment score of 0.24 beat Flag Ship Acquisition's score of 0.00 indicating that C4 Therapeutics is being referred to more favorably in the media.

Company	Overall Sentiment
C4 Therapeutics	Neutral
Flag Ship Acquisition	Neutral

78.8% of C4 Therapeutics shares are owned by institutional investors. Comparatively, 4.1% of Flag Ship Acquisition shares are owned by institutional investors. 5.6% of C4 Therapeutics shares are owned by company insiders. Comparatively, 15.1% of Flag Ship Acquisition shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Flag Ship Acquisition has lower revenue, but higher earnings than C4 Therapeutics. C4 Therapeutics is trading at a lower price-to-earnings ratio than Flag Ship Acquisition, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
C4 Therapeutics	$35.95M	11.61	-$104.99M	-$1.19	N/A
Flag Ship Acquisition	$4.11M	23.78	-$6.17M	-$159.65	N/A

Summary

C4 Therapeutics beats Flag Ship Acquisition on 11 of the 16 factors compared between the two stocks.

How does Flag Ship Acquisition compare to Autolus Therapeutics?

Autolus Therapeutics (NASDAQ:AUTL) and Flag Ship Acquisition (NASDAQ:ETHZ) are both small-cap pharmaceutical products companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability.

Autolus Therapeutics has a beta of 2.02, meaning that its stock price is 102% more volatile than the broader market. Comparatively, Flag Ship Acquisition has a beta of 1.17, meaning that its stock price is 17% more volatile than the broader market.

Flag Ship Acquisition has lower revenue, but higher earnings than Autolus Therapeutics. Autolus Therapeutics is trading at a lower price-to-earnings ratio than Flag Ship Acquisition, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Autolus Therapeutics	$75.39M	5.28	-$287.53M	-$1.09	N/A
Flag Ship Acquisition	$4.11M	23.78	-$6.17M	-$159.65	N/A

Flag Ship Acquisition has a net margin of 0.00% compared to Autolus Therapeutics' net margin of -311.98%. Autolus Therapeutics' return on equity of -128.59% beat Flag Ship Acquisition's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Autolus Therapeutics	-311.98%	-128.59%	-46.25%
Flag Ship Acquisition	N/A	-185.71%	-83.12%

Autolus Therapeutics currently has a consensus target price of $8.75, indicating a potential upside of 485.28%. Given Autolus Therapeutics' stronger consensus rating and higher possible upside, research analysts plainly believe Autolus Therapeutics is more favorable than Flag Ship Acquisition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Autolus Therapeutics	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	2.89
Flag Ship Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

72.8% of Autolus Therapeutics shares are held by institutional investors. Comparatively, 4.1% of Flag Ship Acquisition shares are held by institutional investors. 25.7% of Autolus Therapeutics shares are held by insiders. Comparatively, 15.1% of Flag Ship Acquisition shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Autolus Therapeutics had 4 more articles in the media than Flag Ship Acquisition. MarketBeat recorded 4 mentions for Autolus Therapeutics and 0 mentions for Flag Ship Acquisition. Autolus Therapeutics' average media sentiment score of 0.34 beat Flag Ship Acquisition's score of 0.00 indicating that Autolus Therapeutics is being referred to more favorably in the media.

Company	Overall Sentiment
Autolus Therapeutics	Neutral
Flag Ship Acquisition	Neutral

Summary

Autolus Therapeutics beats Flag Ship Acquisition on 13 of the 17 factors compared between the two stocks.

How does Flag Ship Acquisition compare to Eupraxia Pharmaceuticals?

Eupraxia Pharmaceuticals (NASDAQ:EPRX) and Flag Ship Acquisition (NASDAQ:ETHZ) are both small-cap pharmaceutical products companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, risk, valuation, profitability, earnings, institutional ownership, dividends and media sentiment.

Eupraxia Pharmaceuticals has a beta of 0.98, meaning that its stock price is 2% less volatile than the broader market. Comparatively, Flag Ship Acquisition has a beta of 1.17, meaning that its stock price is 17% more volatile than the broader market.

In the previous week, Eupraxia Pharmaceuticals had 3 more articles in the media than Flag Ship Acquisition. MarketBeat recorded 3 mentions for Eupraxia Pharmaceuticals and 0 mentions for Flag Ship Acquisition. Eupraxia Pharmaceuticals' average media sentiment score of 0.62 beat Flag Ship Acquisition's score of 0.00 indicating that Eupraxia Pharmaceuticals is being referred to more favorably in the media.

Company	Overall Sentiment
Eupraxia Pharmaceuticals	Positive
Flag Ship Acquisition	Neutral

4.1% of Flag Ship Acquisition shares are owned by institutional investors. 15.1% of Flag Ship Acquisition shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Eupraxia Pharmaceuticals currently has a consensus target price of $18.33, suggesting a potential upside of 204.79%. Given Eupraxia Pharmaceuticals' stronger consensus rating and higher probable upside, analysts plainly believe Eupraxia Pharmaceuticals is more favorable than Flag Ship Acquisition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Eupraxia Pharmaceuticals	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	2 Strong Buy rating(s)	2.88
Flag Ship Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Flag Ship Acquisition has higher revenue and earnings than Eupraxia Pharmaceuticals. Eupraxia Pharmaceuticals is trading at a lower price-to-earnings ratio than Flag Ship Acquisition, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Eupraxia Pharmaceuticals	N/A	N/A	-$38.58M	-$1.05	N/A
Flag Ship Acquisition	$4.11M	23.78	-$6.17M	-$159.65	N/A

Eupraxia Pharmaceuticals' return on equity of -87.56% beat Flag Ship Acquisition's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Eupraxia Pharmaceuticals	N/A	-87.56%	-51.20%
Flag Ship Acquisition	N/A	-185.71%	-83.12%

Summary

Eupraxia Pharmaceuticals beats Flag Ship Acquisition on 9 of the 15 factors compared between the two stocks.

How does Flag Ship Acquisition compare to SNDL?

SNDL (NASDAQ:SNDL) and Flag Ship Acquisition (NASDAQ:ETHZ) are both small-cap pharmaceutical products companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, institutional ownership, risk, analyst recommendations and media sentiment.

SNDL has a beta of 0.91, indicating that its stock price is 9% less volatile than the broader market. Comparatively, Flag Ship Acquisition has a beta of 1.17, indicating that its stock price is 17% more volatile than the broader market.

4.1% of Flag Ship Acquisition shares are held by institutional investors. 15.1% of Flag Ship Acquisition shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Flag Ship Acquisition has lower revenue, but higher earnings than SNDL. SNDL is trading at a lower price-to-earnings ratio than Flag Ship Acquisition, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SNDL	$677.32M	0.54	-$11.29M	-$0.03	N/A
Flag Ship Acquisition	$4.11M	23.78	-$6.17M	-$159.65	N/A

Flag Ship Acquisition has a net margin of 0.00% compared to SNDL's net margin of -1.19%. SNDL's return on equity of -1.02% beat Flag Ship Acquisition's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SNDL	-1.19%	-1.02%	-0.85%
Flag Ship Acquisition	N/A	-185.71%	-83.12%

SNDL currently has a consensus price target of $5.00, suggesting a potential upside of 253.36%. Given SNDL's stronger consensus rating and higher possible upside, research analysts plainly believe SNDL is more favorable than Flag Ship Acquisition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SNDL	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Flag Ship Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, SNDL had 2 more articles in the media than Flag Ship Acquisition. MarketBeat recorded 2 mentions for SNDL and 0 mentions for Flag Ship Acquisition. SNDL's average media sentiment score of 0.66 beat Flag Ship Acquisition's score of 0.00 indicating that SNDL is being referred to more favorably in the media.

Company	Overall Sentiment
SNDL	Positive
Flag Ship Acquisition	Neutral

Summary

SNDL beats Flag Ship Acquisition on 9 of the 16 factors compared between the two stocks.

How does Flag Ship Acquisition compare to Rezolute?

Flag Ship Acquisition (NASDAQ:ETHZ) and Rezolute (NASDAQ:RZLT) are both small-cap pharmaceutical products companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, valuation, profitability, dividends, earnings and media sentiment.

4.1% of Flag Ship Acquisition shares are owned by institutional investors. Comparatively, 83.0% of Rezolute shares are owned by institutional investors. 15.1% of Flag Ship Acquisition shares are owned by company insiders. Comparatively, 14.8% of Rezolute shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Rezolute's return on equity of -58.82% beat Flag Ship Acquisition's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Flag Ship Acquisition	N/A	-185.71%	-83.12%
Rezolute	N/A	-58.82%	-54.48%

Rezolute has a consensus price target of $9.38, indicating a potential upside of 102.70%. Given Rezolute's stronger consensus rating and higher possible upside, analysts clearly believe Rezolute is more favorable than Flag Ship Acquisition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Flag Ship Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Rezolute	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.64

Flag Ship Acquisition has a beta of 1.17, suggesting that its share price is 17% more volatile than the broader market. Comparatively, Rezolute has a beta of 0.68, suggesting that its share price is 32% less volatile than the broader market.

In the previous week, Rezolute had 4 more articles in the media than Flag Ship Acquisition. MarketBeat recorded 4 mentions for Rezolute and 0 mentions for Flag Ship Acquisition. Rezolute's average media sentiment score of 0.38 beat Flag Ship Acquisition's score of 0.00 indicating that Rezolute is being referred to more favorably in the news media.

Company	Overall Sentiment
Flag Ship Acquisition	Neutral
Rezolute	Neutral

Flag Ship Acquisition has higher revenue and earnings than Rezolute. Rezolute is trading at a lower price-to-earnings ratio than Flag Ship Acquisition, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Flag Ship Acquisition	$4.11M	23.78	-$6.17M	-$159.65	N/A
Rezolute	N/A	N/A	-$74.41M	-$0.82	N/A

Summary

Rezolute beats Flag Ship Acquisition on 9 of the 14 factors compared between the two stocks.

Get Flag Ship Acquisition News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ETHZ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ETHZ vs. The Competition

Export

Metric	Flag Ship Acquisition	Industry	Manufacturing Sector	NASDAQ Exchange
Market Cap	$97.72M	$2.98B	$4.33B	$12.24B
Dividend Yield	N/A	15.26%	10.25%	5.66%
P/E Ratio	-0.03	13.65	22.28	24.49
Price / Sales	23.78	3,130.75	172.32	138.52
Price / Cash	N/A	26.81	40.19	37.92
Price / Book	0.18	4.93	25.80	6.76
Net Income	-$6.17M	-$39.47M	$116.61M	$337.21M
7 Day Performance	-3.20%	1.35%	1.42%	2.07%
1 Month Performance	38.92%	1.40%	1.03%	3.95%
1 Year Performance	N/A	16.51%	14.41%	29.04%

Flag Ship Acquisition Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ETHZ Flag Ship Acquisition	N/A	$5.14 -3.9%	N/A	N/A	$97.72M	$4.11M	N/A	7
CCCC C4 Therapeutics	1.8473 of 5 stars	$3.87 +8.1%	$7.75 +100.3%	+127.4%	$395.83M	$35.95M	N/A	150	Positive News Gap Up
AUTL Autolus Therapeutics	3.6172 of 5 stars	$1.48 +1.4%	$8.75 +491.2%	-29.2%	$388.59M	$75.39M	N/A	330	Analyst Upgrade
EPRX Eupraxia Pharmaceuticals	2.2267 of 5 stars	$5.92 -0.7%	$18.33 +209.7%	+61.1%	$387.51M	N/A	N/A	29
SNDL SNDL	3.9213 of 5 stars	$1.45 -0.7%	$5.00 +244.8%	+10.9%	$375.80M	$677.32M	N/A	2,751

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ETHZ) was last updated on 6/16/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Flag Ship Acquisition (ETHZ) Competitors

ETHZ vs. CCCC, AUTL, EPRX, SNDL, and RZLT

How does Flag Ship Acquisition compare to C4 Therapeutics?

Summary

How does Flag Ship Acquisition compare to Autolus Therapeutics?

Summary

How does Flag Ship Acquisition compare to Eupraxia Pharmaceuticals?

Summary

How does Flag Ship Acquisition compare to SNDL?

Summary

How does Flag Ship Acquisition compare to Rezolute?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ETHZ vs. The Competition

Flag Ship Acquisition Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Flag Ship Acquisition (ETHZ) Competitors

ETHZ vs. CCCC, AUTL, EPRX, SNDL, and RZLT

How does Flag Ship Acquisition compare to C4 Therapeutics?

Is CCCC or ETHZ more profitable?

Which has more volatility & risk, CCCC or ETHZ?

Do analysts recommend CCCC or ETHZ?

Does the media prefer CCCC or ETHZ?

Do institutionals & insiders have more ownership in CCCC or ETHZ?

Which has higher earnings & valuation, CCCC or ETHZ?

Summary

How does Flag Ship Acquisition compare to Autolus Therapeutics?

Which has more volatility & risk, AUTL or ETHZ?

Which has preferable valuation and earnings, AUTL or ETHZ?

Is AUTL or ETHZ more profitable?

Do analysts rate AUTL or ETHZ?

Do institutionals and insiders have more ownership in AUTL or ETHZ?

Does the media refer more to AUTL or ETHZ?

Summary

How does Flag Ship Acquisition compare to Eupraxia Pharmaceuticals?

Which has more risk and volatility, EPRX or ETHZ?

Does the media prefer EPRX or ETHZ?

Do insiders and institutionals hold more shares of EPRX or ETHZ?

Do analysts rate EPRX or ETHZ?

Which has preferable valuation & earnings, EPRX or ETHZ?

Is EPRX or ETHZ more profitable?

Summary

How does Flag Ship Acquisition compare to SNDL?

Which has more volatility & risk, SNDL or ETHZ?

Do institutionals & insiders hold more shares of SNDL or ETHZ?

Which has preferable earnings & valuation, SNDL or ETHZ?

Is SNDL or ETHZ more profitable?

Do analysts recommend SNDL or ETHZ?

Does the media refer more to SNDL or ETHZ?

Summary

How does Flag Ship Acquisition compare to Rezolute?

Do insiders and institutionals believe in ETHZ or RZLT?

Is ETHZ or RZLT more profitable?

Do analysts rate ETHZ or RZLT?

Which has more volatility & risk, ETHZ or RZLT?

Does the media refer more to ETHZ or RZLT?

Which has stronger valuation & earnings, ETHZ or RZLT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ETHZ vs. The Competition

Flag Ship Acquisition Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools